- Book学术

发布求助

文献互助智能选刊最新文献

IF 1.7 Q2 Medicine

Advances in integrative medicine Pub Date : 2025-01-08 DOI:10.1016/j.aimed.2025.01.003

Hulya Ertas , Burcu Caner , Birol Ocak , Sibel Oyucu Orhan , Erdem Cubukcu , Ozkan Kanat

{"title":"Evaluation of complementary and alternative medicine use in cancer patients: A survey study in Turkey","authors":"Hulya Ertas , Burcu Caner , Birol Ocak , Sibel Oyucu Orhan , Erdem Cubukcu , Ozkan Kanat","doi":"10.1016/j.aimed.2025.01.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>This study aimed to evaluate the characteristics of cancer patients using complementary medicine (CM) and determine possible herb-drug interactions.</div></div><div><h3>Methods</h3><div>We prepared a questionnaire about CM, that included questions about the frequency of CM use, the reasons for using CM, if there was any side effect, CM’s cost, the patient's expectations of CM, whether the following doctor was aware of the patient's CM use, and whether it should be paid for by health insurance, and asked patients to fill it out at the chemotherapy unit. Socio-demographic characteristics and medical data of patients including cancer type, stage, and current treatment protocol were also noted. The data was analyzed using SPSS Statics version 26.</div></div><div><h3>Results</h3><div>245 patients participated in the study. The prevalence of CM use was 34.7 %. The median number of herbal supplements used per patient was 3. CM users were younger [CM user group mean age 54.74 ( ± 12.17), CM non-user group mean age 58.07 ( ± 12.70), p = 0.04]. No other significant difference was found between the CM users and CM non-users. The majority of patients used Propolis (40 %), Curcuma longa (38.8 %), and Nigella sativa (32.9 %). 72.9 % of patients were using CM to complement chemotherapy's efficacy by boosting immunity; 58.8 % were using it to mitigate the side effects of chemotherapy, 34.1 % to treat cancer, and 2.4 % to prevent recurrence. 94.1 % of CM users declared that they were satisfied with CM, 7 patients (8.2 %) reported side effects such as cutaneous side effects (4), diarrhea (2), and elevated liver function tests (1). 41.2 % of CM users continued CM during chemotherapy and 64 possible CM-drug interactions were identified.</div></div><div><h3>Conclusions</h3><div>CM may be nonharmful and efficient but may also be detrimental because of drug interactions. Physicians should not ignore CM and patients should better be informed about CM by healthcare providers.</div></div>","PeriodicalId":7343,"journal":{"name":"Advances in integrative medicine","volume":"12 1","pages":"Pages 99-103"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212958825000035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

方法我们准备了一份关于中药的调查问卷，其中包括使用中药的频率、使用中药的原因、是否有副作用、中药的费用、患者对中药的期望、随诊医生是否知道患者使用中药以及是否应由医疗保险支付等问题，并要求患者在化疗科填写。此外，还记录了患者的社会人口学特征和医疗数据，包括癌症类型、分期和当前治疗方案。数据使用 SPSS Statics 26 版本进行分析。使用中药的比例为 34.7%。每位患者使用的草药补充剂的中位数为 3 种。中药使用者更年轻[中药使用者组平均年龄为 54.74（± 12.17）岁，中药非使用者组平均年龄为 58.07（± 12.70）岁，P = 0.04]。中药使用者和非中药使用者之间没有其他明显差异。大多数患者使用蜂胶（40%）、莪术（38.8%）和黑木耳（32.9%）。72.9%的患者使用中药提高免疫力，以补充化疗的疗效；58.8%的患者使用中药减轻化疗的副作用，34.1%的患者使用中药治疗癌症，2.4%的患者使用中药预防复发。94.1%的中药使用者表示对中药满意，7 名患者（8.2%）报告了副作用，如皮肤副作用（4 例）、腹泻（2 例）和肝功能检测升高（1 例）。41.2%的中药使用者在化疗期间继续服用中药，并发现了 64 种可能的中药-药物相互作用。医生不应忽视中药，医疗服务提供者也应更好地向患者介绍中药。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Evaluation of complementary and alternative medicine use in cancer patients: A survey study in Turkey

Introduction

This study aimed to evaluate the characteristics of cancer patients using complementary medicine (CM) and determine possible herb-drug interactions.

Methods

We prepared a questionnaire about CM, that included questions about the frequency of CM use, the reasons for using CM, if there was any side effect, CM’s cost, the patient's expectations of CM, whether the following doctor was aware of the patient's CM use, and whether it should be paid for by health insurance, and asked patients to fill it out at the chemotherapy unit. Socio-demographic characteristics and medical data of patients including cancer type, stage, and current treatment protocol were also noted. The data was analyzed using SPSS Statics version 26.

Results

245 patients participated in the study. The prevalence of CM use was 34.7 %. The median number of herbal supplements used per patient was 3. CM users were younger [CM user group mean age 54.74 ( ± 12.17), CM non-user group mean age 58.07 ( ± 12.70), p = 0.04]. No other significant difference was found between the CM users and CM non-users. The majority of patients used Propolis (40 %), Curcuma longa (38.8 %), and Nigella sativa (32.9 %). 72.9 % of patients were using CM to complement chemotherapy's efficacy by boosting immunity; 58.8 % were using it to mitigate the side effects of chemotherapy, 34.1 % to treat cancer, and 2.4 % to prevent recurrence. 94.1 % of CM users declared that they were satisfied with CM, 7 patients (8.2 %) reported side effects such as cutaneous side effects (4), diarrhea (2), and elevated liver function tests (1). 41.2 % of CM users continued CM during chemotherapy and 64 possible CM-drug interactions were identified.

Conclusions

CM may be nonharmful and efficient but may also be detrimental because of drug interactions. Physicians should not ignore CM and patients should better be informed about CM by healthcare providers.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Advances in integrative medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-

CiteScore

3.20

自引率

11.80%

发文量

审稿时长

15 weeks

期刊介绍： Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine. The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner. By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes. International networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.